FUJIFILM Healthcare Europe announces ARIETTA 750 FF ENDO compatibility with FUJIFILM ultrasound endoscopes and endobronchial ultrasound scope
06 sept. 2024 03h00 HE
|
FUJIFILM Europe GmbH
RATINGEN, Germany, Sept. 06, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is excited to announce the compatibility between the high-end Ultrasound system ARIETTA 750 FF ENDO and the...
FUJIFILM Healthcare Europe announces revolutionary Detective Flow Imaging (DFI) technology compatibility with mainstream EG-580UT endoscope
16 juil. 2024 03h00 HE
|
FUJIFILM Europe GmbH
RATINGEN, Germany, July 16, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is pleased to announce that the Detective Flow Imaging feature (DFI) of the premium ARIETTA 850 FF Endo...
Fujifilm Healthcare Europe launches lifelike ESD training simulator EndoGel
19 avr. 2024 03h00 HE
|
FUJIFILM Europe GmbH
RATINGEN, Germany, April 19, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is pleased to announce the launch of EndoGel, a training model designed for performing Endoscopic Submucosal...
FUJIFILM Sonosite Introduces the All-Touchscreen Sonosite ST POCUS System, Designed and Engineered to Support Procedural Workflows
03 juil. 2023 03h00 HE
|
FUJIFILM Sonosite, Inc.
BOTHELL, Wash., July 03, 2023 (GLOBE NEWSWIRE) -- FUJIFILM Sonosite, Inc. – The world leader in point-of-care ultrasound (POCUS) solutions has added to its leading portfolio of systems with the...
Kymanox Acquires EU based Anteris Medical and Anteris Helvetia
02 févr. 2023 13h57 HE
|
Kymanox Corporation
MORRISVILLE, N.C. and HOLZKIRCHEN, Germany and KÜSSNACHT A.R., Switzerland, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Kymanox Corporation (“Kymanox”), a professional services company exclusively...
L'engagement de financement contribue à supprimer les obstacles qui empêchent les Canadiens atteints de diabète de type 1 d'accéder à des technologies conçues pour leur survie.
26 mai 2021 11h00 HE
|
Juvenile Diabetes Research Foundation
TORONTO, 26 mai 2021 (GLOBE NEWSWIRE) -- Chaque jour, pas moins de 300 000 Canadiens atteints de diabète de type 1 (DT1) devront prendre jusqu'à 300 décisions sur leurs soins. Une mauvaise décision...
Funding commitment helps remove barriers to life-saving technology for Canadians living with type 1 diabetes
26 mai 2021 11h00 HE
|
Juvenile Diabetes Research Foundation
TORONTO, May 26, 2021 (GLOBE NEWSWIRE) -- Each day, as many as 300,000 Canadians living with type 1 diabetes (T1D) will make up to 300 decisions about their care. A wrong decision could mean life or...